4//SEC Filing
Hunder Naomi 4
Accession 0001209191-22-006436
CIK 0001671858other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:18 PM ET
Size
9.6 KB
Accession
0001209191-22-006436
Insider Transaction Report
Form 4
Hunder Naomi
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-01+67,500→ 67,500 totalExercise: $4.85Exp: 2032-01-31→ Common Stock (67,500 underlying) - Award
Common Stock
2022-02-01+11,250→ 11,250 total - Award
Stock Option (right to buy)
2022-02-01+42,750→ 42,750 totalExercise: $4.85Exp: 2032-01-31→ Common Stock (42,750 underlying)
Footnotes (3)
- [F1]The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The shares subject to the option vest in equal monthly installments over the 48 months following February 1, 2022.
- [F3]25% of the shares subject to the option vest on February 1, 2023, and the remaining shares will vest monthly thereafter over three years.
Documents
Issuer
Silverback Therapeutics, Inc.
CIK 0001671858
Entity typeother
Related Parties
1- filerCIK 0001832170
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:18 PM ET
- Size
- 9.6 KB